Rafael Holdings, Inc. (RFL) stock
RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
$0.91−0.06 (-5.84%)
Close on Nov 17, 2026Market cap $47.67MP/E –Yield –
Rafael total assets
Total assets on the balance sheet at the end of each period.
Rafael's total assets was $83.06M at Jul 31, 2026. For fiscal 2026 it was $83.06M, down 27.2% from the year before. The highest annual figure on record is $154.06M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | $83.06M | -27.2% |
| FY2025 | Jul 31, 2025 | $114.11M | +17.8% |
| FY2024 | Jul 31, 2024 | $96.83M | -2.0% |
| FY2023 | Jul 31, 2023 | $98.83M | -16.5% |
| FY2022 | Jul 31, 2022 | $118.32M | -23.2% |
| FY2021 | Jul 31, 2021 | $154.06M | +13.0% |
| FY2020 | Jul 31, 2020 | $136.35M | -4.1% |
| FY2019 | Jul 31, 2019 | $142.14M | +21.6% |
| FY2018 | Jul 31, 2018 | $116.92M | +35.6% |
| FY2017 | Jul 31, 2017 | $86.20M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | $83.06M | -27.2% |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | $91.99M | -14.9% |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | $99.32M | +19.6% |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | $105.38M | +20.0% |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | $114.11M | +17.8% |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | $108.10M | +6.4% |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | $83.04M | -21.8% |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | $87.84M | -8.0% |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | $96.83M | -2.0% |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | $101.62M | +5.5% |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | $106.15M | +7.7% |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | $95.50M | -7.5% |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | $98.83M | -16.5% |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | $96.36M | -14.6% |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | $98.55M | -19.6% |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | $103.22M | -20.9% |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | $118.32M | -23.2% |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | $112.78M | -22.9% |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | $122.57M | -16.2% |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | $130.41M | -3.1% |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | $154.06M | +13.0% |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | $146.21M | +6.4% |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | $146.25M | +5.0% |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | $134.62M | -4.1% |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | $136.35M | -4.1% |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | $137.43M | -4.2% |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | $139.24M | -3.4% |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | $140.40M | +20.4% |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | $142.14M | +21.6% |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | $143.45M | +24.7% |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | $144.17M | +85.7% |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | $116.63M | +35.3% |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | $116.92M | – |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | $115.08M | – |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | $77.64M | – |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | $86.20M | – |
See a number that looks wrong?